Inactivated Vaccine Market Report

Global and Region Inactivated Vaccine Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：179
  • REPORT CODE：GMM968393
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Inactivated Vaccine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Inactivated Vaccinemarket, defines the market attractiveness level of Inactivated Vaccine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Inactivated Vaccine industry, describes the types of Inactivated Vaccine market, the applications of major players and the market size, and deeply analyzes the current situation of the global Inactivated Vaccine market and the development prospects and opportunities of Inactivated Vaccine industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Inactivated Vaccine market in Chapter 13.

    By Player:

    • Pfizer (US)

    • Emergent BioSolutions (US)

    • MedImmune (US)

    • CSL Limited (Australia)

    • GlaxoSmithKline (UK)

    • Sanofi Pasteur (France)

    • Johnson & Johnson (US)

    • Serum Institute of India Pvt (India)

    • Astellas Pharma (Japan)

    • Merck & Co (US)

    By Type:

    • Pediatrics

    • Adults

    By End-User:

    • Hospital

    • Medical Center

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Inactivated Vaccine Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Inactivated Vaccine Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Inactivated Vaccine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Inactivated Vaccine Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Inactivated Vaccine Market Analysis and Outlook to 2022

    • 7.1 Global Inactivated Vaccine Consumption (2017-2022)

    • 7.2 United States Inactivated Vaccine Consumption (2017-2022)

    • 7.3 Europe Inactivated Vaccine Consumption (2017-2022)

    • 7.4 China Inactivated Vaccine Consumption (2017-2022)

    • 7.5 Japan Inactivated Vaccine Consumption (2017-2022)

    • 7.6 India Inactivated Vaccine Consumption (2017-2022)

    • 7.7 South Korea Inactivated Vaccine Consumption (2017-2022)

    8 Region and Country-wise Inactivated Vaccine Market Analysis and Outlook to 2028

    • 8.1 Global Inactivated Vaccine Consumption Forecast (2022-2028)

    • 8.2 United States Inactivated Vaccine Consumption Forecast (2022-2028)

    • 8.3 Europe Inactivated Vaccine Consumption Forecast (2022-2028)

    • 8.4 China Inactivated Vaccine Consumption Forecast (2022-2028)

    • 8.5 Japan Inactivated Vaccine Consumption Forecast (2022-2028)

    • 8.6 India Inactivated Vaccine Consumption Forecast (2022-2028)

    • 8.7 South Korea Inactivated Vaccine Consumption Forecast (2022-2028)

    9 Global Inactivated Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global Inactivated Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Pediatrics Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Adults Consumption and Growth Rate (2017-2022)

    • 9.2 Global Inactivated Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Medical Center Consumption and Growth Rate (2017-2022)

    10 Global Inactivated Vaccine Market Outlook by Types and Applications to 2028

    • 10.1 Global Inactivated Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Pediatrics Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Adults Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Inactivated Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Medical Center Consumption Forecast and Growth Rate (2022-2028)

    11 Global Inactivated Vaccine Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Inactivated Vaccine Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Inactivated Vaccine Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Inactivated Vaccine Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Inactivated Vaccine Market Competitive Analysis

    • 14.1 Pfizer (US)

      • 14.1.1 Pfizer (US) Company Details

      • 14.1.2 Pfizer (US) Inactivated Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Pfizer (US) Inactivated Vaccine Product and Service

    • 14.2 Emergent BioSolutions (US)

      • 14.2.1 Emergent BioSolutions (US) Company Details

      • 14.2.2 Emergent BioSolutions (US) Inactivated Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Emergent BioSolutions (US) Inactivated Vaccine Product and Service

    • 14.3 MedImmune (US)

      • 14.3.1 MedImmune (US) Company Details

      • 14.3.2 MedImmune (US) Inactivated Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 MedImmune (US) Inactivated Vaccine Product and Service

    • 14.4 CSL Limited (Australia)

      • 14.4.1 CSL Limited (Australia) Company Details

      • 14.4.2 CSL Limited (Australia) Inactivated Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 CSL Limited (Australia) Inactivated Vaccine Product and Service

    • 14.5 GlaxoSmithKline (UK)

      • 14.5.1 GlaxoSmithKline (UK) Company Details

      • 14.5.2 GlaxoSmithKline (UK) Inactivated Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 GlaxoSmithKline (UK) Inactivated Vaccine Product and Service

    • 14.6 Sanofi Pasteur (France)

      • 14.6.1 Sanofi Pasteur (France) Company Details

      • 14.6.2 Sanofi Pasteur (France) Inactivated Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Sanofi Pasteur (France) Inactivated Vaccine Product and Service

    • 14.7 Johnson & Johnson (US)

      • 14.7.1 Johnson & Johnson (US) Company Details

      • 14.7.2 Johnson & Johnson (US) Inactivated Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Johnson & Johnson (US) Inactivated Vaccine Product and Service

    • 14.8 Serum Institute of India Pvt (India)

      • 14.8.1 Serum Institute of India Pvt (India) Company Details

      • 14.8.2 Serum Institute of India Pvt (India) Inactivated Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Serum Institute of India Pvt (India) Inactivated Vaccine Product and Service

    • 14.9 Astellas Pharma (Japan)

      • 14.9.1 Astellas Pharma (Japan) Company Details

      • 14.9.2 Astellas Pharma (Japan) Inactivated Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Astellas Pharma (Japan) Inactivated Vaccine Product and Service

    • 14.10 Merck & Co (US)

      • 14.10.1 Merck & Co (US) Company Details

      • 14.10.2 Merck & Co (US) Inactivated Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Merck & Co (US) Inactivated Vaccine Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Inactivated Vaccine

    • Figure Inactivated Vaccine Picture

    • Table Global Inactivated Vaccine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Inactivated Vaccine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Inactivated Vaccine Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Inactivated Vaccine Consumption by Country (2017-2022)

    • Figure United States Inactivated Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe Inactivated Vaccine Consumption and Growth Rate (2017-2022)

    • Figure China Inactivated Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan Inactivated Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India Inactivated Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Inactivated Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Inactivated Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States Inactivated Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Inactivated Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Inactivated Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Inactivated Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Inactivated Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Inactivated Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pediatrics Consumption and Growth Rate (2017-2022)

    • Figure Global Adults Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Medical Center Consumption and Growth Rate (2017-2022)

    • Figure Global Pediatrics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adults Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Medical Center Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Inactivated Vaccine Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Inactivated Vaccine Export by Region (Top 5 Countries) (2017-2028)

    • Table Pfizer (US) (Foundation Year, Company Profile and etc.)

    • Table Pfizer (US) Inactivated Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer (US) Inactivated Vaccine Product and Service

    • Table Emergent BioSolutions (US) (Foundation Year, Company Profile and etc.)

    • Table Emergent BioSolutions (US) Inactivated Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Emergent BioSolutions (US) Inactivated Vaccine Product and Service

    • Table MedImmune (US) (Foundation Year, Company Profile and etc.)

    • Table MedImmune (US) Inactivated Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table MedImmune (US) Inactivated Vaccine Product and Service

    • Table CSL Limited (Australia) (Foundation Year, Company Profile and etc.)

    • Table CSL Limited (Australia) Inactivated Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Limited (Australia) Inactivated Vaccine Product and Service

    • Table GlaxoSmithKline (UK) (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline (UK) Inactivated Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline (UK) Inactivated Vaccine Product and Service

    • Table Sanofi Pasteur (France) (Foundation Year, Company Profile and etc.)

    • Table Sanofi Pasteur (France) Inactivated Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pasteur (France) Inactivated Vaccine Product and Service

    • Table Johnson & Johnson (US) (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson (US) Inactivated Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson (US) Inactivated Vaccine Product and Service

    • Table Serum Institute of India Pvt (India) (Foundation Year, Company Profile and etc.)

    • Table Serum Institute of India Pvt (India) Inactivated Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Serum Institute of India Pvt (India) Inactivated Vaccine Product and Service

    • Table Astellas Pharma (Japan) (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma (Japan) Inactivated Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma (Japan) Inactivated Vaccine Product and Service

    • Table Merck & Co (US) (Foundation Year, Company Profile and etc.)

    • Table Merck & Co (US) Inactivated Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co (US) Inactivated Vaccine Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US